chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram T wave inversion, Electrocardiogram abnormal, Fatigue, Headache, Hyperhidrosis
Clinical narrative: Left chest pain within a few hours of shot, along with malaise, diaphoresis. Accompanied by fatigue, chills, fever, nausea, headache over next 48 hours. Other symptoms resolved after 48 hours with rest and 500-650 mg Tylenol 2-3x/day, except chest pain, pleuritic at times, associated at times with nausea, retching, cough, fatigue. Chest pain was 3-5/10 and intermittent, until escalated to 10/10 and awoke me from sleep 60 hours after shot, no longer pleuritic but crushing, associated with sense of doom, nausea/vomiting, and radiation to left ear.  This episode lasted about an hour and returned to 1-2/10 pain after 650 mg Tylenol by the time I reached the ED. Found to have elevated troponin, and cardiac MRI identified myoperciarditis. Admitted for 1 night. Being treated with colchicine and ibuprofen (initially aspirin given contra-indication to NSAIDS due to history of idiopathic angioedema).
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Left ventricular dilatation, Magnetic resonance imaging heart, Malaise, Myocardial oedema, Myocarditis
Clinical narrative: Left chest pain within a few hours of shot, along with malaise, diaphoresis. Accompanied by fatigue, chills, fever, nausea, headache over next 48 hours. Other symptoms resolved after 48 hours with rest and 500-650 mg Tylenol 2-3x/day, except chest pain, pleuritic at times, associated at times with nausea, retching, cough, fatigue. Chest pain was 3-5/10 and intermittent, until escalated to 10/10 and awoke me from sleep 60 hours after shot, no longer pleuritic but crushing, associated with sense of doom, nausea/vomiting, and radiation to left ear.  This episode lasted about an hour and returned to 1-2/10 pain after 650 mg Tylenol by the time I reached the ED. Found to have elevated troponin, and cardiac MRI identified myoperciarditis. Admitted for 1 night. Being treated with colchicine and ibuprofen (initially aspirin given contra-indication to NSAIDS due to history of idiopathic angioedema).
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: N-terminal prohormone brain natriuretic peptide increased, Nausea, Pain, Pericardial fibrosis, Pleuritic pain
Clinical narrative: Left chest pain within a few hours of shot, along with malaise, diaphoresis. Accompanied by fatigue, chills, fever, nausea, headache over next 48 hours. Other symptoms resolved after 48 hours with rest and 500-650 mg Tylenol 2-3x/day, except chest pain, pleuritic at times, associated at times with nausea, retching, cough, fatigue. Chest pain was 3-5/10 and intermittent, until escalated to 10/10 and awoke me from sleep 60 hours after shot, no longer pleuritic but crushing, associated with sense of doom, nausea/vomiting, and radiation to left ear.  This episode lasted about an hour and returned to 1-2/10 pain after 650 mg Tylenol by the time I reached the ED. Found to have elevated troponin, and cardiac MRI identified myoperciarditis. Admitted for 1 night. Being treated with colchicine and ibuprofen (initially aspirin given contra-indication to NSAIDS due to history of idiopathic angioedema).
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Red blood cell sedimentation rate increased, Retching, Sleep disorder, Troponin increased
Clinical narrative: Left chest pain within a few hours of shot, along with malaise, diaphoresis. Accompanied by fatigue, chills, fever, nausea, headache over next 48 hours. Other symptoms resolved after 48 hours with rest and 500-650 mg Tylenol 2-3x/day, except chest pain, pleuritic at times, associated at times with nausea, retching, cough, fatigue. Chest pain was 3-5/10 and intermittent, until escalated to 10/10 and awoke me from sleep 60 hours after shot, no longer pleuritic but crushing, associated with sense of doom, nausea/vomiting, and radiation to left ear.  This episode lasted about an hour and returned to 1-2/10 pain after 650 mg Tylenol by the time I reached the ED. Found to have elevated troponin, and cardiac MRI identified myoperciarditis. Admitted for 1 night. Being treated with colchicine and ibuprofen (initially aspirin given contra-indication to NSAIDS due to history of idiopathic angioedema).
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Ventricular hypokinesia, Vomiting
Clinical narrative: Left chest pain within a few hours of shot, along with malaise, diaphoresis. Accompanied by fatigue, chills, fever, nausea, headache over next 48 hours. Other symptoms resolved after 48 hours with rest and 500-650 mg Tylenol 2-3x/day, except chest pain, pleuritic at times, associated at times with nausea, retching, cough, fatigue. Chest pain was 3-5/10 and intermittent, until escalated to 10/10 and awoke me from sleep 60 hours after shot, no longer pleuritic but crushing, associated with sense of doom, nausea/vomiting, and radiation to left ear.  This episode lasted about an hour and returned to 1-2/10 pain after 650 mg Tylenol by the time I reached the ED. Found to have elevated troponin, and cardiac MRI identified myoperciarditis. Admitted for 1 night. Being treated with colchicine and ibuprofen (initially aspirin given contra-indication to NSAIDS due to history of idiopathic angioedema).
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Blood fibrinogen decreased, Contusion, Fibrin D dimer increased, Platelet count decreased
Clinical narrative: Bruising in the arm that received the injection, extending from wrist to upper chest, restricted to the side of the chest of the arm that received the injection.  This was associated.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blindness, Deafness, Dizziness, Loss of consciousness
Clinical narrative: Several minutes after receiving the vaccine, the patient felt dizzy, went in and out of consciousness, and lost sense of sight and hearing. 911 was called by the pharmacist while the patient was taken care of by the pharmacy technician and patient's accompanying person. The ambulance arrived quickly and the patient claimed to have recovered and felt well enough to go home. EMS allowed her to leave.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Cardiac function test, Chills, Electrocardiogram, Headache
Clinical narrative: Several minutes after receiving the vaccine, the patient felt dizzy, went in and out of consciousness, and lost sense of sight and hearing. 911 was called by the pharmacist while the patient was taken care of by the pharmacy technician and patient's accompanying person. The ambulance arrived quickly and the patient claimed to have recovered and felt well enough to go home. EMS allowed her to leave.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Immediate post-injection reaction, Liver function test, Nausea, Pain in extremity
Clinical narrative: Several minutes after receiving the vaccine, the patient felt dizzy, went in and out of consciousness, and lost sense of sight and hearing. 911 was called by the pharmacist while the patient was taken care of by the pharmacy technician and patient's accompanying person. The ambulance arrived quickly and the patient claimed to have recovered and felt well enough to go home. EMS allowed her to leave.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Renal function test, Syncope
Clinical narrative: Several minutes after receiving the vaccine, the patient felt dizzy, went in and out of consciousness, and lost sense of sight and hearing. 911 was called by the pharmacist while the patient was taken care of by the pharmacy technician and patient's accompanying person. The ambulance arrived quickly and the patient claimed to have recovered and felt well enough to go home. EMS allowed her to leave.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: C-reactive protein increased, Chest pain, Dyspnoea, Electrocardiogram normal, Full blood count normal
Clinical narrative: My arm was sore that night November 4th, 2021, the next afternoon at about 4pm I had chest pain. I called my Cardiologist who refilled my Colchicine. Within thirty-six hours of taking the medication the pain is gone. I still have shortness of breath but that gets better after using my inhaler. I will see my Physician again tomorrow morning, November 11th, 2021.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: My arm was sore that night November 4th, 2021, the next afternoon at about 4pm I had chest pain. I called my Cardiologist who refilled my Colchicine. Within thirty-six hours of taking the medication the pain is gone. I still have shortness of breath but that gets better after using my inhaler. I will see my Physician again tomorrow morning, November 11th, 2021.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested positive with a rapid test during a community outbreak
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Nausea, Pyrexia
Clinical narrative: Pt received full dose of Moderna 0.5ml instead of 0.25 ml on 10/25. I called Moderna on 10/26 to receive vaccine information through email. I called patient on 10/29. She stated that she did experience fever and nausea after getting the vaccine.
Age: 59.0
Sex: M
Vaccine: FLU4
Symptoms: Arthralgia, X-ray limb
Clinical narrative: Right Shoulder Pain.
Age: 80.0
Sex: M
Vaccine: FLU4
Symptoms: Guillain-Barre syndrome
Clinical narrative: Guillan Barre
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeding disorder, Feeling abnormal, Gait inability, Lethargy
Clinical narrative: Unable to walk, unable to eat, speech minimal. Extremely lethargic. Three days. Reactions started approximately 5 to 6 hours after shot.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Speech disorder, Vaccination complication
Clinical narrative: Unable to walk, unable to eat, speech minimal. Extremely lethargic. Three days. Reactions started approximately 5 to 6 hours after shot.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm remains soar after 6 months.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: Client presented to receive Pfizer booster. Client reported  that his first dose went well, however when he received his second dose he felt dizziness/weakness two hours after receiving the second dose on March 17th, 2021. He stated that it lasted 10mins and decided to take Ibuprofen and it went away. He stated the symptoms didn't come back. Client states he had something to eat that day, however he stated he had waited in line for many hours prior to getting vaccinated , he believes that might have caused him to feel dizzy. Medical Consultation was sent to Vaccine supervisors and client was approved to receive Pfizer booster lot#FF8839 on 11/9/21. Prior to vaccination client was given bottled water and crackers. Client was instructed to seek emergency care for any anaphylaxis reaction. Also, to speak to his primary care provider for any non emergency symptoms he might experience. He was instructed to stay well hydrated and eat his meals. Client verbalized understanding. Client walked to observation area after receiving vaccine in a steady gait.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Back pain, Balance disorder, Chills
Clinical narrative: Six (6) hours post-injection, I started feeling tired, which I chalked up to the vaccine as colleagues had reported similar symptoms.  By late evening, the lethargy increased to to point that I retired early for the night, around 8:30pm.  By 9:00pm, chills and a feeling of having a fever overtook me to the point that I thought I had a severe case of the flu.  For the next 2 hours, I was basically trying to remain still and not touch any cool sheet or pillow as it was exceedingly cold to me.  Although I felt as if I had a fever, my temperature remained normal.  At approximately 11:00pm, the "veil" lifted and the chills and "fever sense" were abating.  By 11:30pm, I was able to get out of bed and use the bathroom, albeit somewhat weak, unsteady and having lower back soreness.  Sleep was uneasy for the remainder of the night but I did manage some.  When I awakened at 7:30am, the only symptoms were the previously reported lower back pain and now all my joints were sore.  As of late afternoon, the back soreness ended, but the joint soreness continues even now at 3:00pm, but is lessened with ibuprofen.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling cold, Feeling hot, Poor quality sleep
Clinical narrative: Six (6) hours post-injection, I started feeling tired, which I chalked up to the vaccine as colleagues had reported similar symptoms.  By late evening, the lethargy increased to to point that I retired early for the night, around 8:30pm.  By 9:00pm, chills and a feeling of having a fever overtook me to the point that I thought I had a severe case of the flu.  For the next 2 hours, I was basically trying to remain still and not touch any cool sheet or pillow as it was exceedingly cold to me.  Although I felt as if I had a fever, my temperature remained normal.  At approximately 11:00pm, the "veil" lifted and the chills and "fever sense" were abating.  By 11:30pm, I was able to get out of bed and use the bathroom, albeit somewhat weak, unsteady and having lower back soreness.  Sleep was uneasy for the remainder of the night but I did manage some.  When I awakened at 7:30am, the only symptoms were the previously reported lower back pain and now all my joints were sore.  As of late afternoon, the back soreness ended, but the joint soreness continues even now at 3:00pm, but is lessened with ibuprofen.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: injection site warm, swollen, and hard to the touch
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: covid symptoms and positive test
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested positive with a rapid test during a community outbreak
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Received the 2nd Pfizer vaccine mid-morning. Went to bed and woke up with itchy hives on my body. It lasted 10 days.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Hypoaesthesia, Hypoaesthesia oral, Swollen tongue
Clinical narrative: received her Moderna Booster vaccine 11/4/2021 at approximately 10:20am. She reported to nursing staff that she started to feel numbness in the lips and lower cheek 10 minutes after being vaccinated. No swelling of the lips, tongue, throat upon initial assessment and no shortness of breath. She stated she had no previous reaction to first 2 doses of Moderna. Patient drank some water and finished her observation period with frequent nursing reassessments. She reported no changes throughout, except for the report of mild tongue swelling at the end of her 30 min obs. Pt denied shortness of breath or trouble swallowing. Instructed patient to follow up at Urgent Care immediately to be seen by an MD. She verbalized understanding and left the COVID Vaccine Clinic at 10:55am.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Fall, Loss of consciousness, SARS-CoV-2 test positive
Clinical narrative: FALL W/ LOC
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebellar infarction, Magnetic resonance imaging head abnormal
Clinical narrative: Patient received vaccine 11/5/21 and was admitted to the hospital 11/7/21 for an acute right cerebellar infarct
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Arthralgia, Headache, Miliaria, Petechiae
Clinical narrative: Throat started to swell and began to lose my voice. Headache, horrible joint pain and heat rash on throat and neck. Petechiae rash across back of neck, shoulders and arms. Doctor provided intravenous Benadryl and steroids at time of shot.  Went back to the doctor on July 15th and they have me another round of intravenous steroids.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Rash
Clinical narrative: Throat started to swell and began to lose my voice. Headache, horrible joint pain and heat rash on throat and neck. Petechiae rash across back of neck, shoulders and arms. Doctor provided intravenous Benadryl and steroids at time of shot.  Went back to the doctor on July 15th and they have me another round of intravenous steroids.
Age: 81.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Pain in extremity
Clinical narrative: Patient complained of severe arm pain starting the evening of 11/8/21. 5" x 4" area of redness and swelling on the back of the arm and 4.5" x 3.75" area of redness and swelling on the right bicep started the next day. Patient took Benadryl 50 mg at bedtime on 11/09/21 and 25 mg in the am on 11/10/21 and started Cortisone cream on the evening of 11/09/21. Patient presented to the office on 11/10/21 to have the area looked at. Redness and swelling has improved to 4" x 3.5" on the back of the arm and 3.5" x3.25" on the bicep. Patient is to continue Benadryl 25 mg tonight and Cortisone cream.
Age: 24.0
Sex: U
Vaccine: COVID19
Symptoms: Lip pruritus, Pruritus
Clinical narrative: itching to face/lips after their first Pfizer dose
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Respiratory tract congestion, Wheezing
Clinical narrative: Sore throat, muscle ache, congestion, wheezing for 9 days.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Balance disorder, Fatigue, Nausea
Clinical narrative: Anxiety, nausea. fatigue, exhaustion, equilibrium issues.
Age: 18.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Two series of COVID19 vaccine  Received Moderna 09/03/2021 Recieved Janssen 09/13/2021  Refugee number A-241540920  The  Regulatory Authority has been requested to enter all COVID vaccines into system. The teams responsible for screening and administering vaccines to the refugees at the Vaccine site were/are all on duty staff. Staff is assisting with entering information into database and VAERS. Is assisting with entering information into Database and VAERS.
Age: 11.0
Sex: U
Vaccine: FLU4
Symptoms: Product storage error
Clinical narrative: Vaccine exposed to temperature outside recommended storage range. Unknown viability potency per manufacturer.
Age: 96.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID-19 infection
Age: 42.0
Sex: M
Vaccine: FLU4
Symptoms: Blood glucose increased, Pollakiuria, Thirst, Type 1 diabetes mellitus
Clinical narrative: I was diagnosed with type I diabetes on 2/14/2020 and I believe it is a direct result of the Flu shot that I received that year.  The first symptoms (frequent urination, increased thirst) that I can recall started on 11/15/2019,  but symptoms could have started sooner.  It's hard to say for sure but I know I didn't have any prior to 10/7/2019.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: redness and swelling at injection site
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: High fever of 102 degrees for 2 days.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Fatigue, Headache, Nausea
Clinical narrative: - Left Arm soreness - Back ache and all around body aches - Headache - Fatigue - Nausea - Chest Pain
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, SARS-CoV-2 test
Clinical narrative: - Left Arm soreness - Back ache and all around body aches - Headache - Fatigue - Nausea - Chest Pain
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Pt states she went to ER and DX with Covid was given IV fluids on 11/7/21
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chills, Decreased appetite, Diarrhoea, Dizziness
Clinical narrative: diaphoresis, lightheadedness, getting shaky and nervous, "hot flashes" Heart Palpitations, loss of appetite and diarrhea, chills, headache
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Hot flush, Hyperhidrosis, Nervousness, Palpitations
Clinical narrative: diaphoresis, lightheadedness, getting shaky and nervous, "hot flashes" Heart Palpitations, loss of appetite and diarrhea, chills, headache
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Tremor
Clinical narrative: diaphoresis, lightheadedness, getting shaky and nervous, "hot flashes" Heart Palpitations, loss of appetite and diarrhea, chills, headache
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Death, Myalgia
Clinical narrative: developed weakness and myalgias  10/17/2021. admitted to Hospital and died on 10/20/2021
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Rectal haemorrhage
Clinical narrative: rectal bleeding started a few days after vaccine and ongoing
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Acidosis, Ageusia, Alanine aminotransferase normal, Anion gap, Anisocytosis
Clinical narrative: Date of Admission: 10/29/2021   Date of Death:11/4/2021   Reason for Hospital Admission (Admitting Diagnosis):  Covid-19 pneumonia   Hospital Course and Significant Findings: Patient  is a 76 Y male with a past medical history of  COPD, HTN, HFrEF (last EF 36% on TTE 2019) who presents with 1-week hx of worsening SOB in setting of recently diagnosed COVID-19.    Patient reports that he has had shortness of breath in last few years. He has a hx of COPD and was being followed by pulmonologists. However, last week after returning from a trip patient started having increasing SOB and cough productive of sputum. He reports that it has been gradually getting worse. He uses inhalers at home which minimally helped. He also took Robitussin which seemed to have greatly helped his cough. However, the SOB is now to the point that he has difficulty breathing w/movement and sometimes w/talking. These were associated w/loss of taste / smell, headache, and nausea. Patient denies vomiting, abdominal pain, diarrhea, fevers, chills, or night sweats. Patient reports he may have been exposed to COVID + patient while on a trip where he was attending mother's funeral. He and other attendees ended up being positive for COVID a few days after returning from trip.    On admission, patient started on Remdesivir (10/29-11/2), Decadron 6 mg x1 (10/29), but due to escalation of oxygen requirements, steroids were changed to Solumedrol 125 mg BID (10/29 PM-11/1 AM), Solumedrol 60 mg BID (11/1 PM-11/2), and patient given dose of Tocilizumab 8 mg/kg x1 after discussion w/pulmonology (Dr.). Pt's O2 requirements continued to increase, 11/1 requiring 10 L. 11/2 was on 7 L, but desaturated to high 80s with any movement or speech. On 11/4 AM, pt complained of significantly increased chest pain which limited his breathing, was placed on max oximizer. Status continued to decline and transitioned to max HFNC with NRB (60 L), and ICU was consulted.   On examination, pt was obtunded, unable to clear secretions, appeared dusky, satting in high 80s on HFNC w/ NRB. Anesthesia was called for intubation. Pt was intubated, bagged, transferred to ICU.   Upon arrival to ICU, pt went into PEA arrest, code blue was called. Converted to vfib, then shock administered and pt had ROSC. Central line, arterial line chest tube were placed and pressors, sedation, paralytics initiated.    Pt continued to be hypotensive with worsening O2 saturations on max pressors. Bronchoscopy revealed significant blood. Pt was severely acidotic, hypotension worsening despite pressors. Discussed w/ family pt's imminent passing and was made DNR/DNI, passed at 1500.    Complications: none
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Anosmia, Aspartate aminotransferase increased, Band neutrophil percentage increased, Blood albumin normal, Blood alkaline phosphatase normal
Clinical narrative: Date of Admission: 10/29/2021   Date of Death:11/4/2021   Reason for Hospital Admission (Admitting Diagnosis):  Covid-19 pneumonia   Hospital Course and Significant Findings: Patient  is a 76 Y male with a past medical history of  COPD, HTN, HFrEF (last EF 36% on TTE 2019) who presents with 1-week hx of worsening SOB in setting of recently diagnosed COVID-19.    Patient reports that he has had shortness of breath in last few years. He has a hx of COPD and was being followed by pulmonologists. However, last week after returning from a trip patient started having increasing SOB and cough productive of sputum. He reports that it has been gradually getting worse. He uses inhalers at home which minimally helped. He also took Robitussin which seemed to have greatly helped his cough. However, the SOB is now to the point that he has difficulty breathing w/movement and sometimes w/talking. These were associated w/loss of taste / smell, headache, and nausea. Patient denies vomiting, abdominal pain, diarrhea, fevers, chills, or night sweats. Patient reports he may have been exposed to COVID + patient while on a trip where he was attending mother's funeral. He and other attendees ended up being positive for COVID a few days after returning from trip.    On admission, patient started on Remdesivir (10/29-11/2), Decadron 6 mg x1 (10/29), but due to escalation of oxygen requirements, steroids were changed to Solumedrol 125 mg BID (10/29 PM-11/1 AM), Solumedrol 60 mg BID (11/1 PM-11/2), and patient given dose of Tocilizumab 8 mg/kg x1 after discussion w/pulmonology (Dr.). Pt's O2 requirements continued to increase, 11/1 requiring 10 L. 11/2 was on 7 L, but desaturated to high 80s with any movement or speech. On 11/4 AM, pt complained of significantly increased chest pain which limited his breathing, was placed on max oximizer. Status continued to decline and transitioned to max HFNC with NRB (60 L), and ICU was consulted.   On examination, pt was obtunded, unable to clear secretions, appeared dusky, satting in high 80s on HFNC w/ NRB. Anesthesia was called for intubation. Pt was intubated, bagged, transferred to ICU.   Upon arrival to ICU, pt went into PEA arrest, code blue was called. Converted to vfib, then shock administered and pt had ROSC. Central line, arterial line chest tube were placed and pressors, sedation, paralytics initiated.    Pt continued to be hypotensive with worsening O2 saturations on max pressors. Bronchoscopy revealed significant blood. Pt was severely acidotic, hypotension worsening despite pressors. Discussed w/ family pt's imminent passing and was made DNR/DNI, passed at 1500.    Complications: none
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Blood bilirubin normal, Blood chloride normal, Blood creatinine increased, Blood culture, Blood glucose normal
Clinical narrative: Date of Admission: 10/29/2021   Date of Death:11/4/2021   Reason for Hospital Admission (Admitting Diagnosis):  Covid-19 pneumonia   Hospital Course and Significant Findings: Patient  is a 76 Y male with a past medical history of  COPD, HTN, HFrEF (last EF 36% on TTE 2019) who presents with 1-week hx of worsening SOB in setting of recently diagnosed COVID-19.    Patient reports that he has had shortness of breath in last few years. He has a hx of COPD and was being followed by pulmonologists. However, last week after returning from a trip patient started having increasing SOB and cough productive of sputum. He reports that it has been gradually getting worse. He uses inhalers at home which minimally helped. He also took Robitussin which seemed to have greatly helped his cough. However, the SOB is now to the point that he has difficulty breathing w/movement and sometimes w/talking. These were associated w/loss of taste / smell, headache, and nausea. Patient denies vomiting, abdominal pain, diarrhea, fevers, chills, or night sweats. Patient reports he may have been exposed to COVID + patient while on a trip where he was attending mother's funeral. He and other attendees ended up being positive for COVID a few days after returning from trip.    On admission, patient started on Remdesivir (10/29-11/2), Decadron 6 mg x1 (10/29), but due to escalation of oxygen requirements, steroids were changed to Solumedrol 125 mg BID (10/29 PM-11/1 AM), Solumedrol 60 mg BID (11/1 PM-11/2), and patient given dose of Tocilizumab 8 mg/kg x1 after discussion w/pulmonology (Dr.). Pt's O2 requirements continued to increase, 11/1 requiring 10 L. 11/2 was on 7 L, but desaturated to high 80s with any movement or speech. On 11/4 AM, pt complained of significantly increased chest pain which limited his breathing, was placed on max oximizer. Status continued to decline and transitioned to max HFNC with NRB (60 L), and ICU was consulted.   On examination, pt was obtunded, unable to clear secretions, appeared dusky, satting in high 80s on HFNC w/ NRB. Anesthesia was called for intubation. Pt was intubated, bagged, transferred to ICU.   Upon arrival to ICU, pt went into PEA arrest, code blue was called. Converted to vfib, then shock administered and pt had ROSC. Central line, arterial line chest tube were placed and pressors, sedation, paralytics initiated.    Pt continued to be hypotensive with worsening O2 saturations on max pressors. Bronchoscopy revealed significant blood. Pt was severely acidotic, hypotension worsening despite pressors. Discussed w/ family pt's imminent passing and was made DNR/DNI, passed at 1500.    Complications: none
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Blood potassium increased, Blood sodium decreased, Blood urea increased, Brain natriuretic peptide normal, Bronchoscopy abnormal
Clinical narrative: Date of Admission: 10/29/2021   Date of Death:11/4/2021   Reason for Hospital Admission (Admitting Diagnosis):  Covid-19 pneumonia   Hospital Course and Significant Findings: Patient  is a 76 Y male with a past medical history of  COPD, HTN, HFrEF (last EF 36% on TTE 2019) who presents with 1-week hx of worsening SOB in setting of recently diagnosed COVID-19.    Patient reports that he has had shortness of breath in last few years. He has a hx of COPD and was being followed by pulmonologists. However, last week after returning from a trip patient started having increasing SOB and cough productive of sputum. He reports that it has been gradually getting worse. He uses inhalers at home which minimally helped. He also took Robitussin which seemed to have greatly helped his cough. However, the SOB is now to the point that he has difficulty breathing w/movement and sometimes w/talking. These were associated w/loss of taste / smell, headache, and nausea. Patient denies vomiting, abdominal pain, diarrhea, fevers, chills, or night sweats. Patient reports he may have been exposed to COVID + patient while on a trip where he was attending mother's funeral. He and other attendees ended up being positive for COVID a few days after returning from trip.    On admission, patient started on Remdesivir (10/29-11/2), Decadron 6 mg x1 (10/29), but due to escalation of oxygen requirements, steroids were changed to Solumedrol 125 mg BID (10/29 PM-11/1 AM), Solumedrol 60 mg BID (11/1 PM-11/2), and patient given dose of Tocilizumab 8 mg/kg x1 after discussion w/pulmonology (Dr.). Pt's O2 requirements continued to increase, 11/1 requiring 10 L. 11/2 was on 7 L, but desaturated to high 80s with any movement or speech. On 11/4 AM, pt complained of significantly increased chest pain which limited his breathing, was placed on max oximizer. Status continued to decline and transitioned to max HFNC with NRB (60 L), and ICU was consulted.   On examination, pt was obtunded, unable to clear secretions, appeared dusky, satting in high 80s on HFNC w/ NRB. Anesthesia was called for intubation. Pt was intubated, bagged, transferred to ICU.   Upon arrival to ICU, pt went into PEA arrest, code blue was called. Converted to vfib, then shock administered and pt had ROSC. Central line, arterial line chest tube were placed and pressors, sedation, paralytics initiated.    Pt continued to be hypotensive with worsening O2 saturations on max pressors. Bronchoscopy revealed significant blood. Pt was severely acidotic, hypotension worsening despite pressors. Discussed w/ family pt's imminent passing and was made DNR/DNI, passed at 1500.    Complications: none
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, COVID-19, COVID-19 pneumonia, Carbon dioxide normal, Cardio-respiratory arrest
Clinical narrative: Date of Admission: 10/29/2021   Date of Death:11/4/2021   Reason for Hospital Admission (Admitting Diagnosis):  Covid-19 pneumonia   Hospital Course and Significant Findings: Patient  is a 76 Y male with a past medical history of  COPD, HTN, HFrEF (last EF 36% on TTE 2019) who presents with 1-week hx of worsening SOB in setting of recently diagnosed COVID-19.    Patient reports that he has had shortness of breath in last few years. He has a hx of COPD and was being followed by pulmonologists. However, last week after returning from a trip patient started having increasing SOB and cough productive of sputum. He reports that it has been gradually getting worse. He uses inhalers at home which minimally helped. He also took Robitussin which seemed to have greatly helped his cough. However, the SOB is now to the point that he has difficulty breathing w/movement and sometimes w/talking. These were associated w/loss of taste / smell, headache, and nausea. Patient denies vomiting, abdominal pain, diarrhea, fevers, chills, or night sweats. Patient reports he may have been exposed to COVID + patient while on a trip where he was attending mother's funeral. He and other attendees ended up being positive for COVID a few days after returning from trip.    On admission, patient started on Remdesivir (10/29-11/2), Decadron 6 mg x1 (10/29), but due to escalation of oxygen requirements, steroids were changed to Solumedrol 125 mg BID (10/29 PM-11/1 AM), Solumedrol 60 mg BID (11/1 PM-11/2), and patient given dose of Tocilizumab 8 mg/kg x1 after discussion w/pulmonology (Dr.). Pt's O2 requirements continued to increase, 11/1 requiring 10 L. 11/2 was on 7 L, but desaturated to high 80s with any movement or speech. On 11/4 AM, pt complained of significantly increased chest pain which limited his breathing, was placed on max oximizer. Status continued to decline and transitioned to max HFNC with NRB (60 L), and ICU was consulted.   On examination, pt was obtunded, unable to clear secretions, appeared dusky, satting in high 80s on HFNC w/ NRB. Anesthesia was called for intubation. Pt was intubated, bagged, transferred to ICU.   Upon arrival to ICU, pt went into PEA arrest, code blue was called. Converted to vfib, then shock administered and pt had ROSC. Central line, arterial line chest tube were placed and pressors, sedation, paralytics initiated.    Pt continued to be hypotensive with worsening O2 saturations on max pressors. Bronchoscopy revealed significant blood. Pt was severely acidotic, hypotension worsening despite pressors. Discussed w/ family pt's imminent passing and was made DNR/DNI, passed at 1500.    Complications: none
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Cardioversion, Central venous catheterisation, Chest pain, Chest tube insertion, Condition aggravated
Clinical narrative: Date of Admission: 10/29/2021   Date of Death:11/4/2021   Reason for Hospital Admission (Admitting Diagnosis):  Covid-19 pneumonia   Hospital Course and Significant Findings: Patient  is a 76 Y male with a past medical history of  COPD, HTN, HFrEF (last EF 36% on TTE 2019) who presents with 1-week hx of worsening SOB in setting of recently diagnosed COVID-19.    Patient reports that he has had shortness of breath in last few years. He has a hx of COPD and was being followed by pulmonologists. However, last week after returning from a trip patient started having increasing SOB and cough productive of sputum. He reports that it has been gradually getting worse. He uses inhalers at home which minimally helped. He also took Robitussin which seemed to have greatly helped his cough. However, the SOB is now to the point that he has difficulty breathing w/movement and sometimes w/talking. These were associated w/loss of taste / smell, headache, and nausea. Patient denies vomiting, abdominal pain, diarrhea, fevers, chills, or night sweats. Patient reports he may have been exposed to COVID + patient while on a trip where he was attending mother's funeral. He and other attendees ended up being positive for COVID a few days after returning from trip.    On admission, patient started on Remdesivir (10/29-11/2), Decadron 6 mg x1 (10/29), but due to escalation of oxygen requirements, steroids were changed to Solumedrol 125 mg BID (10/29 PM-11/1 AM), Solumedrol 60 mg BID (11/1 PM-11/2), and patient given dose of Tocilizumab 8 mg/kg x1 after discussion w/pulmonology (Dr.). Pt's O2 requirements continued to increase, 11/1 requiring 10 L. 11/2 was on 7 L, but desaturated to high 80s with any movement or speech. On 11/4 AM, pt complained of significantly increased chest pain which limited his breathing, was placed on max oximizer. Status continued to decline and transitioned to max HFNC with NRB (60 L), and ICU was consulted.   On examination, pt was obtunded, unable to clear secretions, appeared dusky, satting in high 80s on HFNC w/ NRB. Anesthesia was called for intubation. Pt was intubated, bagged, transferred to ICU.   Upon arrival to ICU, pt went into PEA arrest, code blue was called. Converted to vfib, then shock administered and pt had ROSC. Central line, arterial line chest tube were placed and pressors, sedation, paralytics initiated.    Pt continued to be hypotensive with worsening O2 saturations on max pressors. Bronchoscopy revealed significant blood. Pt was severely acidotic, hypotension worsening despite pressors. Discussed w/ family pt's imminent passing and was made DNR/DNI, passed at 1500.    Complications: none
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Death, Depressed level of consciousness, Differential white blood cell count, Dyspnoea
Clinical narrative: Date of Admission: 10/29/2021   Date of Death:11/4/2021   Reason for Hospital Admission (Admitting Diagnosis):  Covid-19 pneumonia   Hospital Course and Significant Findings: Patient  is a 76 Y male with a past medical history of  COPD, HTN, HFrEF (last EF 36% on TTE 2019) who presents with 1-week hx of worsening SOB in setting of recently diagnosed COVID-19.    Patient reports that he has had shortness of breath in last few years. He has a hx of COPD and was being followed by pulmonologists. However, last week after returning from a trip patient started having increasing SOB and cough productive of sputum. He reports that it has been gradually getting worse. He uses inhalers at home which minimally helped. He also took Robitussin which seemed to have greatly helped his cough. However, the SOB is now to the point that he has difficulty breathing w/movement and sometimes w/talking. These were associated w/loss of taste / smell, headache, and nausea. Patient denies vomiting, abdominal pain, diarrhea, fevers, chills, or night sweats. Patient reports he may have been exposed to COVID + patient while on a trip where he was attending mother's funeral. He and other attendees ended up being positive for COVID a few days after returning from trip.    On admission, patient started on Remdesivir (10/29-11/2), Decadron 6 mg x1 (10/29), but due to escalation of oxygen requirements, steroids were changed to Solumedrol 125 mg BID (10/29 PM-11/1 AM), Solumedrol 60 mg BID (11/1 PM-11/2), and patient given dose of Tocilizumab 8 mg/kg x1 after discussion w/pulmonology (Dr.). Pt's O2 requirements continued to increase, 11/1 requiring 10 L. 11/2 was on 7 L, but desaturated to high 80s with any movement or speech. On 11/4 AM, pt complained of significantly increased chest pain which limited his breathing, was placed on max oximizer. Status continued to decline and transitioned to max HFNC with NRB (60 L), and ICU was consulted.   On examination, pt was obtunded, unable to clear secretions, appeared dusky, satting in high 80s on HFNC w/ NRB. Anesthesia was called for intubation. Pt was intubated, bagged, transferred to ICU.   Upon arrival to ICU, pt went into PEA arrest, code blue was called. Converted to vfib, then shock administered and pt had ROSC. Central line, arterial line chest tube were placed and pressors, sedation, paralytics initiated.    Pt continued to be hypotensive with worsening O2 saturations on max pressors. Bronchoscopy revealed significant blood. Pt was severely acidotic, hypotension worsening despite pressors. Discussed w/ family pt's imminent passing and was made DNR/DNI, passed at 1500.    Complications: none
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea exertional, Endotracheal intubation, Fibrin D dimer, Glomerular filtration rate decreased, Haematocrit decreased
Clinical narrative: Date of Admission: 10/29/2021   Date of Death:11/4/2021   Reason for Hospital Admission (Admitting Diagnosis):  Covid-19 pneumonia   Hospital Course and Significant Findings: Patient  is a 76 Y male with a past medical history of  COPD, HTN, HFrEF (last EF 36% on TTE 2019) who presents with 1-week hx of worsening SOB in setting of recently diagnosed COVID-19.    Patient reports that he has had shortness of breath in last few years. He has a hx of COPD and was being followed by pulmonologists. However, last week after returning from a trip patient started having increasing SOB and cough productive of sputum. He reports that it has been gradually getting worse. He uses inhalers at home which minimally helped. He also took Robitussin which seemed to have greatly helped his cough. However, the SOB is now to the point that he has difficulty breathing w/movement and sometimes w/talking. These were associated w/loss of taste / smell, headache, and nausea. Patient denies vomiting, abdominal pain, diarrhea, fevers, chills, or night sweats. Patient reports he may have been exposed to COVID + patient while on a trip where he was attending mother's funeral. He and other attendees ended up being positive for COVID a few days after returning from trip.    On admission, patient started on Remdesivir (10/29-11/2), Decadron 6 mg x1 (10/29), but due to escalation of oxygen requirements, steroids were changed to Solumedrol 125 mg BID (10/29 PM-11/1 AM), Solumedrol 60 mg BID (11/1 PM-11/2), and patient given dose of Tocilizumab 8 mg/kg x1 after discussion w/pulmonology (Dr.). Pt's O2 requirements continued to increase, 11/1 requiring 10 L. 11/2 was on 7 L, but desaturated to high 80s with any movement or speech. On 11/4 AM, pt complained of significantly increased chest pain which limited his breathing, was placed on max oximizer. Status continued to decline and transitioned to max HFNC with NRB (60 L), and ICU was consulted.   On examination, pt was obtunded, unable to clear secretions, appeared dusky, satting in high 80s on HFNC w/ NRB. Anesthesia was called for intubation. Pt was intubated, bagged, transferred to ICU.   Upon arrival to ICU, pt went into PEA arrest, code blue was called. Converted to vfib, then shock administered and pt had ROSC. Central line, arterial line chest tube were placed and pressors, sedation, paralytics initiated.    Pt continued to be hypotensive with worsening O2 saturations on max pressors. Bronchoscopy revealed significant blood. Pt was severely acidotic, hypotension worsening despite pressors. Discussed w/ family pt's imminent passing and was made DNR/DNI, passed at 1500.    Complications: none
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Headache, Hypotension, Intensive care, International normalised ratio increased
Clinical narrative: Date of Admission: 10/29/2021   Date of Death:11/4/2021   Reason for Hospital Admission (Admitting Diagnosis):  Covid-19 pneumonia   Hospital Course and Significant Findings: Patient  is a 76 Y male with a past medical history of  COPD, HTN, HFrEF (last EF 36% on TTE 2019) who presents with 1-week hx of worsening SOB in setting of recently diagnosed COVID-19.    Patient reports that he has had shortness of breath in last few years. He has a hx of COPD and was being followed by pulmonologists. However, last week after returning from a trip patient started having increasing SOB and cough productive of sputum. He reports that it has been gradually getting worse. He uses inhalers at home which minimally helped. He also took Robitussin which seemed to have greatly helped his cough. However, the SOB is now to the point that he has difficulty breathing w/movement and sometimes w/talking. These were associated w/loss of taste / smell, headache, and nausea. Patient denies vomiting, abdominal pain, diarrhea, fevers, chills, or night sweats. Patient reports he may have been exposed to COVID + patient while on a trip where he was attending mother's funeral. He and other attendees ended up being positive for COVID a few days after returning from trip.    On admission, patient started on Remdesivir (10/29-11/2), Decadron 6 mg x1 (10/29), but due to escalation of oxygen requirements, steroids were changed to Solumedrol 125 mg BID (10/29 PM-11/1 AM), Solumedrol 60 mg BID (11/1 PM-11/2), and patient given dose of Tocilizumab 8 mg/kg x1 after discussion w/pulmonology (Dr.). Pt's O2 requirements continued to increase, 11/1 requiring 10 L. 11/2 was on 7 L, but desaturated to high 80s with any movement or speech. On 11/4 AM, pt complained of significantly increased chest pain which limited his breathing, was placed on max oximizer. Status continued to decline and transitioned to max HFNC with NRB (60 L), and ICU was consulted.   On examination, pt was obtunded, unable to clear secretions, appeared dusky, satting in high 80s on HFNC w/ NRB. Anesthesia was called for intubation. Pt was intubated, bagged, transferred to ICU.   Upon arrival to ICU, pt went into PEA arrest, code blue was called. Converted to vfib, then shock administered and pt had ROSC. Central line, arterial line chest tube were placed and pressors, sedation, paralytics initiated.    Pt continued to be hypotensive with worsening O2 saturations on max pressors. Bronchoscopy revealed significant blood. Pt was severely acidotic, hypotension worsening despite pressors. Discussed w/ family pt's imminent passing and was made DNR/DNI, passed at 1500.    Complications: none